Le Lézard
Classified in: Health
Subjects: PER, PET, ANW

Pet Honesty Appoints Steve Chopp as Chief Financial Officer


AUSTIN, Texas, Sept. 27, 2022 /PRNewswire/ -- Pet Honesty, a trusted leader in premium pet health products, announced that Steve Chopp has joined the firm as Chief Financial Officer. Pet Honesty is a portfolio company of Vestar Capital Partners.

Mr. Chopp brings more than 20 years of experience in leadership roles at high-growth, health and nutrition companies. Most recently, he served as CFO and COO for Bragg Live Food Products, the number one brand of apple cider vinegar, where he oversaw the finance, supply chain, and technology functions. Additionally, Mr. Chopp spent more than 15 years working in the rapid growth supplements industry, including eight years at Pharmavite, the makers of Nature Made vitamins and supplements, where he served as EVP and CFO. He also held senior roles in consulting with L.E.K. Consulting and Stern Stewart & Co. Mr. Chopp holds an MBA from Indiana University's Kelley School of Business and a B.S. in finance from California Polytechnic State University-San Luis Obispo.

"Steve is an accomplished leader with broad experience developing and executing high-impact strategies. He will be an invaluable asset as we continue our mission to elevate pet vitality to deliver more joyful moments for pet parents," said Richard Greenberg, CEO of Pet Honesty.

"As Pet Honesty's recent partnership with Petco illustrates, the Company is on a strong growth trajectory, and I look forward to partnering with the senior team during this exciting time as the Company continues to expand and deliver on its strategic plan," said Mr. Chopp.

About Pet Honesty
Pet Honesty, a trusted leader in premium, natural pet health products, is on a mission to help pet parents elevate their pet's vitality for more joyful moments together. Founded originally as an innovative e-commerce brand in 2018 and headquartered in Austin, TX, the company specializes in vet-approved pet supplements made with natural base ingredients and premium active ingredients, providing functional pet health benefits backed by science and certified by the NASC. Pet Honesty products are formulated in an FDA registered facility in the U.S.A. and available for purchase online at Pethonesty.com, Amazon, Chewy, Petco.com, and at Petco retail stores nationwide and select neighborhood pet retailers. For personalized guidance and education about Pet Honesty products, visit Pethonesty.com and follow @PetHonesty on Facebook, Instagram, TikTok and LinkedIn.

About Vestar Capital Partners
Vestar Capital Partners is a leading U.S. middle-market private equity firm specializing in management buyouts and growth capital investments. Vestar invests and collaborates with incumbent management teams and private owners to build long-term enterprise value, with a focus on Consumer, Business & Technology Services and Healthcare. Since inception in 1988, Vestar funds have invested $11 billion in 89 companies ? as well as more than 200 add-on acquisitions ? with a total value of approximately $52 billion. For more information on Vestar, please visit www.vestarcapital.com.

Media Contact:

Lambert
Jennifer Hurson
845-507-0571
[email protected]
or
Joanne Lessner
212-222-7436
[email protected]

 

SOURCE Pet Honesty; Vestar Capital Partners


These press releases may also interest you

at 18:27
Andreozzi + Foote is deeply troubled by revelations of sexual abuse perpetrated by Ramon Garcia against patients at Carbon Health Urgent Care in Jenkintown and possibly other locations. Our client, Jane Doe, bravely stepped forward to share her...

at 18:14
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...



News published on and distributed by: